Research programme: propiconazole derivative nanoparticle - Astellas Pharma
Alternative Names: MXP-4509Latest Information Update: 16 Jul 2016
At a glance
- Originator Unknown
- Class Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Candidiasis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Candidiasis in Romania
- 12 Sep 2012 Early research in Candidiasis in Romania (unspecified route)